Cytokines and mycoses

D. A. Stevens; T. J. Walsh; F. Bistoni; E. Cenci; K. V. Clemons; G. Del Sero; C. F.È D'Ostiani; B. J. Kullberg; A. Mencacci; E. Roilides; L. Romani

Cytokines and mycoses

D. A. Stevens, T. J. Walsh, F. Bistoni, E. Cenci, K. V. Clemons, G. Del Sero, C. F.È D'Ostiani, B. J. Kullberg, A. Mencacci, E. Roilides, L. Romani

School of Medicine

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Abstract

Cell-mediated immunity (CMI) has been shown, over many decades of clinical observation and bench research, to be central to the outcome of invasive fungal infections. In recent years, understanding the role of messenger molecules (cytokines), in coordinating and augmenting cellular immunity has been ascendant. These studies have made it possible to consider using cytokines, now available in abundant quantities via recombinant DNA technologies, to treat fungal infections. In this symposium, the most important fungal pathogens that cause infections in humans, particularly in immunocompromised patients, are considered, with emphasis on how recent experimental work may lead to a better understanding of the role of cytokines and their use in therapy.

Original language	English (US)
Pages (from-to)	174-182
Number of pages	9
Journal	Medical Mycology, Supplement
Volume	36
Issue number	1
State	Published - Dec 1 1998

Keywords

Cell-mediated immunity
Cytokines
Immunology
Immunotherapy
Mycoses

ASJC Scopus subject areas

Microbiology
Immunology

Cite this

@article{ce13721069a34e7198435bcd0c3d0ee0,

title = "Cytokines and mycoses",

abstract = "Cell-mediated immunity (CMI) has been shown, over many decades of clinical observation and bench research, to be central to the outcome of invasive fungal infections. In recent years, understanding the role of messenger molecules (cytokines), in coordinating and augmenting cellular immunity has been ascendant. These studies have made it possible to consider using cytokines, now available in abundant quantities via recombinant DNA technologies, to treat fungal infections. In this symposium, the most important fungal pathogens that cause infections in humans, particularly in immunocompromised patients, are considered, with emphasis on how recent experimental work may lead to a better understanding of the role of cytokines and their use in therapy.",

keywords = "Cell-mediated immunity, Cytokines, Immunology, Immunotherapy, Mycoses",

author = "Stevens, {D. A.} and Walsh, {T. J.} and F. Bistoni and E. Cenci and Clemons, {K. V.} and {Del Sero}, G. and D'Ostiani, {C. F.{\`E}} and Kullberg, {B. J.} and A. Mencacci and E. Roilides and L. Romani",

year = "1998",

month = dec,

day = "1",

language = "English (US)",

volume = "36",

pages = "174--182",

journal = "Medical Mycology, Supplement",

issn = "0966-8454",

publisher = "Taylor and Francis Ltd.",

number = "1",

}

TY - JOUR

T1 - Cytokines and mycoses

AU - Stevens, D. A.

AU - Walsh, T. J.

AU - Bistoni, F.

AU - Cenci, E.

AU - Clemons, K. V.

AU - Del Sero, G.

AU - D'Ostiani, C. F.È

AU - Kullberg, B. J.

AU - Mencacci, A.

AU - Roilides, E.

AU - Romani, L.

PY - 1998/12/1

Y1 - 1998/12/1

N2 - Cell-mediated immunity (CMI) has been shown, over many decades of clinical observation and bench research, to be central to the outcome of invasive fungal infections. In recent years, understanding the role of messenger molecules (cytokines), in coordinating and augmenting cellular immunity has been ascendant. These studies have made it possible to consider using cytokines, now available in abundant quantities via recombinant DNA technologies, to treat fungal infections. In this symposium, the most important fungal pathogens that cause infections in humans, particularly in immunocompromised patients, are considered, with emphasis on how recent experimental work may lead to a better understanding of the role of cytokines and their use in therapy.

AB - Cell-mediated immunity (CMI) has been shown, over many decades of clinical observation and bench research, to be central to the outcome of invasive fungal infections. In recent years, understanding the role of messenger molecules (cytokines), in coordinating and augmenting cellular immunity has been ascendant. These studies have made it possible to consider using cytokines, now available in abundant quantities via recombinant DNA technologies, to treat fungal infections. In this symposium, the most important fungal pathogens that cause infections in humans, particularly in immunocompromised patients, are considered, with emphasis on how recent experimental work may lead to a better understanding of the role of cytokines and their use in therapy.

KW - Cell-mediated immunity

KW - Cytokines

KW - Immunology

KW - Immunotherapy

KW - Mycoses

UR - http://www.scopus.com/inward/record.url?scp=2042423023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2042423023&partnerID=8YFLogxK

M3 - Article

C2 - 9988506

AN - SCOPUS:2042423023

SN - 0966-8454

VL - 36

SP - 174

EP - 182

JO - Medical Mycology, Supplement

JF - Medical Mycology, Supplement

IS - 1

ER -

Cytokines and mycoses

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this